Search bioRxiv⌕ Search

Biology subjects

Haruna, S.

Publications and source records attributed to Haruna, S..

2 recordsLinked to original sources

Accurate and scalable multi-disease classification from adaptive immune repertoires

BackgroundMachine learning models trained on paratope-similarity networks have shown superior accuracy compared with clonotype-based models in binary disease classification. However, the computational demands of paratope networks hinder their use on large datasets and multi-disease classification. MethodsWe reanalyzed publicly available T cell receptor (TCR) repertoire data from 1,421 donors across 15 disease groups and a large control group, encompassing approximately 81 million TCR sequences. To address computational bottlenecks, we replaced the paratope-similarity network approach (Paratope Cluster Occupancy or PCO) with a new Fast Approximate Clustering Techniques (FACTS) pipeline, which is comprised of four main steps: (1) high-dimensional vector encoding of sequences; (2) efficient clustering of the resulting vectors; (3) donor-level feature construction from cluster distributions; and (4) gradient-boosted decision tree classification for multi-class disease prediction. FindingsFACTS processed 107 sequences in under 120 CPU hours. Using only TCR data, and evaluated with 5-fold cross-validation, it achieved a mean ROC AUC of 0.99 across 16 disease classes. Compared with the recently reported Mal-ID model, FACTS achieved higher donor-level classification accuracy for BCR (0.840 vs. 0.740), TCR (0.882 vs. 0.751), and combined BCR+TCR datasets (0.904 vs. 0.853) on the six-class Mal-ID benchmark. FACTS also preserved biologically meaningful signals, as shown by unsupervised t-SNE projections revealing distinct disease-associated and potentially age-associated clusters. InterpretationParatope-based encoding with FACTS-derived features provides a scalable and biologically grounded approach for adaptive immune receptor (AIR) repertoire classification. The resulting classifier achieves superior multi-disease diagnostic performance while maintaining interpretability, supporting its potential for clinical and population-scale health profiling. FundingThis study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI [JA23H034980], the Japan Agency for Medical Research and Development (AMED) [JP25am0101001], and the Kishimoto Foundation Fellowship. Research in contextO_ST_ABSEvidence before this studyC_ST_ABST and B cell receptor (TCR and BCR) repertoires encode lifelong immunological memory and antigen-specific responses, making them valuable biomarkers for disease diagnosis and prediction. Existing machine learning (ML) models for adaptive immune receptor (AIR) repertoires often rely on clonotype-based representations, which limit shared receptor detection between donors and thus reduce cross-individual disease signature detection. Most models also lack robust multi-disease, population-scale performance. Our previous work showed that representing repertoires as paratope-similarity networks increased the fraction of shared receptors between donors and improved disease classification. However, their computational complexity has limited their scalability for the large datasets required in multi-disease classification. Added value of this studyWe introduce FACTS, a unified ML framework integrating paratope similarity with scalable sequence encoding. Applied to TCR repertoires from 1,421 donors across 15 diseases and one control group, FACTS maintained high performance while efficiently processing 81 million sequences on standard CPU infrastructure. Compared to Mal-ID, our paratope-encoded method achieved significantly higher donor-level accuracy and revealed biologically meaningful disease- and potentially age-associated patterns. Implications of all the available evidenceFACTS offers high accuracy, and interpretability for multi-disease classification, bringing AIR repertoire-based diagnostics closer to clinical translation and potentially guiding precision immunotherapy and immune-based therapeutic discovery for a wide range of diseases.

bioinformatics↗

Generalizable features for the diagnosis of infectious disease, autoimmunity and cancer from adaptive immune receptor repertoires

Liquid biopsies based on peripheral blood offer a minimally invasive alternative to solid tissue biopsies for the detection of diseases, primarily cancers. However, such tests currently consider only the serum component of blood, overlooking a potentially rich source of biomarkers: adaptive immune receptors (AIRs) expressed on circulating B and T cells. Machine learning-based classifiers trained on AIRs have been reported to accurately identify not only cancers, but also autoimmune and infectious diseases as well. However, when using the conventional "clonotype cluster" representation of AIRs, donors within a disease or healthy cohort exhibit vastly different features, limiting the generalizability of these classifiers. This paper addresses the challenge of classifying specific diseases from circulating B or T cells by developing a novel representation of AIRs based on similarity networks constructed from their antigen-binding regions (paratopes). Features based on this novel representation, paratope cluster occupancies (PCOs), significantly improved disease classification performance for infectious disease, autoimmunity and cancer. Under identical methodological conditions, classifiers trained on PCOs achieved a mean ROC AUC of 0.893 when applied to new donors, compared to clonotype cluster-based classifiers (0.714) or the best-performing published classifier (0.777). Surprisingly, for cancer patients, we observed that some of the AIRs that were important for classification were significantly more abundant in healthy controls than in individuals with disease. These "healthy-biased" AIRs were predicted to target known cancer-associated antigens at dramatically higher rates than healthy AIRs as a whole (Z scores > 75), suggesting the existence of an overlooked reservoir of cancer-targeting immune cells that are diagnostic and identifiable from a routine blood test. Consequently, PCOs not only enhance classification of a broad range of diseases but also identify immune cells with therapeutic potential.

bioinformatics↗